Yong Han

Mr. Yong Han


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2015 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
ZCZhe Cheng
Zhe Cheng
HWHang Zhou Wang
Hang Zhou Wang
XLXuetao Li
Xuetao Li
ZWZhiwu Wu
Zhiwu Wu
YHYong Han
Yong Han
YZYouxin Zhou
Youxin Zhou
MiRNA-184 is an oncogene in human hepatocellular carcinoma but acts as a tumor suppressor in tongue squamous cell carcinoma. Studies have shown that miR-184 was down-regulated in glioma and TNFα-induced protein 2 (TNFAIP2) was closely related to tumorigenesis. This study aimed to determine the functions of miR-184 in glioma and the mechanisms of miRNA-184-TNFAIP2 mediated glioma progression. Real-time reverse-transcription PCR detected expression of miR-184 and TNFAIP2. U87 and U251 cells were transfected with miR-184 mimic, inhibitor, or negative control miRNA, and their invasion abilities were assayed. Cellular proliferation was measured by the cell counting kit-8 assay. miR-184 effects on glioma cell apoptosis and cell cycle were assessed by flow cytometer. Biological information software have predicted that miR-184 could target TNFα-induced protein 2 (TNFAIP2), Which was further validated by Western blot and qRT-PCR in glioma cells. In vivo, U87 cells transduced with either lentiviral over-expressed miR-184 or control lentivirus were injected into nude mice subcutaneously and intracranial respectively. Expression of miR-184 was significantly lower in glioma tissues and cell-lines compared to normal brain tissues. Protein and mRNA expression of TNFAIP2 were inversely correlated with miR-184 in glioma. In vitro, proliferation and invasion abilities were also decreased in U87 and U251 cells after transfection with miR-184 mimic. In vivo, the xenografted tumor size in the miR-184 overexpressing group were smaller than the miR-NC group. Concordantly, U87 and U251 cells transfected with miR-184 mimic had a higher apoptosis rate, triggering an accumulation of cells at the G0/G1 phase and decreased cells in S-phase. miR-184 could regulate TNFAIP2 expression and affected its translation in glioma. miR-184 could also inhibit glioma progression and might serve as a novel therapeutic target in glioma.

10 September 2025 in World Neurosurgery
Verified
Journal Article
Open access
WYWei Yin
Wei Yin
YHYong Han
Yong Han
To investigate the clinical efficacy of cranial reduction surgery in treating children with rupture of middle cranial fossa arachnoid cysts complicated by cranial deformity and to provide reference for clinical treatment. This study retrospectively analyzed the clinical and imaging data of 5 children with rupture and hemorrhage of middle cranial fossa arachnoid cysts who underwent surgical treatment in the Department of Neurosurgery, Children's Hospital of Soochow University, from July 2016 to June 2024. All children had cranial deformities caused by arachnoid cysts, and they were all male with a median age of 6 years (range, 4-8 years). Among them, 3 children had arachnoid cysts located in the right temporal region, 1 in the left temporal region, and 1 involved both temporal regions. All children received a comprehensive treatment plan including craniotomy for hematoma evacuation, cystocephalostomy, subdural drainage, and cranial reduction surgery. The median follow-up time for the 5 children was 19 months (range, 6-97 months). Compared with preoperatively, all children and their families reported varying degrees of improvement in cranial appearance after the surgery. The volume of arachnoid cysts was reduced to varying degrees, and no recurrence of cyst rupture or hemorrhage occurred. When selecting a treatment plan for arachnoid cysts, it is essential to take into account the clinical symptoms and imaging findings of the children. For cases where the rupture of arachnoid cysts leads to refractory chronic bleeding or acute bleeding that cannot be effectively managed by burr hole drainage to evacuate the hematoma and relieve intracranial hypertension, and when the children also present with cranial deformity, the combined treatment plan of craniotomy for hematoma evacuation and cranial reduction surgery may be a viable option. This surgical approach not only effectively removes intracranial hematomas and alleviates intracranial hypertension but also improves cranial deformity. However, further research is needed to determine whether this surgical approach can reduce the recurrence rate of arachnoid cyst rupture and bleeding.